Date | Title | Description | Source |
19.12.2022 | STORM Therapeutics announces closing of USD $30M Series B fi... | 14 December, 2022. Cambridge, England. STORM Therapeutics Ltd. (STORM), the clinical biotechnology c... | seroba-lif... |
14.12.2022 | STORM Therapeutics Ltd - STORM Therapeutics announces closin... |
STORM Therapeutics announces closing of USD $30M Series B financing
Proceeds will advance STO... | ipgroupplc... |
14.12.2022 | Storm Therapeutics Closes USD $30M Series B Financing | Storm Therapeutics, a Cambridge, UK-based clinical biotechnology company, raised $30M in Series B fi... | finsmes.co... |
14.12.2022 | STORM Therapeutics announces closing of USD $30M Series B fi... | STORM Therapeutics announces closing of USD $30M Series B financing
Proceeds will advance STORM’s p... | cic.vc/new... |
23.11.2022 | STORM Therapeutics doses first patient with oral METTL3 targ... | STORM Therapeutics doses first patient with oral METTL3 targeting drug in a solid tumor Phase 1 stud... | cic.vc/new... |
23.11.2022 | STORM Therapeutics doses first patient with oral METTL3 targ... | STC-15 is the first molecule specifically targeting an RNA methyltransferase to enter clinical devel... | einpresswi... |
20.10.2022 | STORM Therapeutics to present new data on its lead program S... | STORM Therapeutics to present new data on its lead program STC-15 at the 34th EORTC-NCI-AACR Symposi... | cic.vc/new... |
12.09.2022 | Fierce Biotech names STORM Therapeutics as one of its “Fierc... | Fierce Biotech names STORM Therapeutics as one of its “Fierce 15” Biotech Companies of 2022
STORM r... | cic.vc/new... |
04.05.2022 | STORM Therapeutics funded to fight coronavirus diseases | STORM Therapeutics funded to fight coronavirus diseases
Business Weekly article | By Tony Quested
... | cic.vc/new... |
14.10.2021 | Exelixis and STORM enter into exclusive collaboration to dis... | Exelixis and STORM Therapeutics enter into exclusive collaboration and license agreement to discover... | cic.vc/new... |
26.04.2021 | STORM Therapeutics publishes data in Nature showing its firs... | STORM Therapeutics publishes data in Nature showing its first-in-class inhibitor of METTL3 is effect... | cic.vc/new... |
30.12.2020 | Storm Therapeutics announces publication of “RNA-Modifying E... | Storm Therapeutics announces publication of “RNA-Modifying Enzymes and their Inhibitors” in 2020 Med... | cic.vc/new... |
22.10.2020 | Storm Therapeutics selects first-in-class clinical candidate... | STORM Therapeutics selects first-in-class clinical candidate targeting METTL3
STORM Therapeutics, t... | cic.vc/new... |
20.05.2019 | Storm Therapeutics Raises Additional £14M in Series A Totall... | Storm Therapeutics, a Cambridge, England, UK-based drug discovery company tackling disease through m... | finsmes.co... |
20.05.2019 | STORM Therapeutics - STORM Therapeutics Extends Series A to ... |
STORM Therapeutics ("STORM"), the drug discovery company tackling disease through modula... | ipgroupplc... |
09.01.2018 | Term Sheet — Tuesday, January 9 | A DYNAMITE YEAR
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see... | fortune.co... |
09.01.2018 | Storm Therapeutics Raises £4M in Series A Funding | Storm Therapeutics, a Cambridge, MA-based drug discovery company focused on small molecule therapies... | finsmes.co... |
08.01.2018 | Taiho invests in STORM Therapeutics | STORM Therapeutics has raised an additional £4 million of funding from Taiho Ventures, LLC the strat... | cic.vc/new... |
27.11.2017 | Nature publication on RNA epigenetics by STORM Therapeutics ... | New drug target discovered for Acute Myeloid Leukaemia
STORM Therapeutics announced the publication... | cic.vc/new... |
06.11.2017 | Professor Paul Workman joins the board of STORM Therapeutics | STORM Therapeutics has announced the appointment of Professor Paul Workman to its Board. This appoin... | cic.vc/new... |
28.07.2017 | Cambridge spin-out STORM Therapeutics expands collaboration ... | Evotec AG announced an integrated drug discovery collaboration with STORM Therapeutics to develop ne... | cambridgen... |
28.07.2017 | Cambridge spin-out STORM Therapeutics expands collaboration ... | Cambridge spin-out STORM Therapeutics expands collaboration with Evotec
28-07-2017
Evotec AG annou... | cambridgen... |
29.03.2017 | Postscript designs a new website for RNA epigenetics pioneer... | Postscript designs a new website for RNA epigenetics pioneer STORM Therapeutics
29-03-2017
Web des... | cambridgen... |
24.02.2017 | Storm Therapeutics appoints CEO and Chairman | Storm Therapeutics moved to the next stage of its development with the appointment of Keith Blundy a... | cic.vc/new... |
28.06.2016 | Cancer Drug Development Company Storm Therapeutics Raises £1... | Storm Therapeutics, a Cambridge, UK-based cancer drug development company, secured £12m in Series A ... | finsmes.co... |
28.06.2016 | Storm Therapeutics raises £12m in Series 'A' funding | Storm Therapeutics raises £12m in Series 'A' funding
28-06-2016
Cambridge Innovation Capital has i... | cambridgen... |
- | STORM Therapeutics selects first-in-class clinical candidate... | Cambridge, UK. 22 October 2020. Seroba’s investee company, STORM Therapeutics, the leading biotechno... | seroba-lif... |
- | FutureNeuro partners with STORM Therapeutics to explore the ... | Dublin, Ireland. 9 September 2020. FutureNeuro has announced that it has entered into partnership wi... | seroba-lif... |
- | Storm Therapeutics | “STORM Therapeutics is a pioneer in the field of RNA epigenetics. We are an emerging biotechnology c... | fastfounde... |
- | Storm Therapeutics and Evotec Leverage Indigo Platform to Pr... | Hamburg, Germany. 17 November 2020. Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0... | seroba-lif... |
- | Exelixis and STORM Therapeutics Enter into Exclusive Collabo... | California, USA and Cambridge, UK. 14 October 2021.
STORM to deliver small molecule ADAR1 clinical ... | seroba-lif... |